title: Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
abstract: Alemtuzumab was first used in multiple sclerosis in 1991. It is a monoclonal antibody which is directed against CD52, a protein of unknown function on lymphocytes. Alemtuzumab causes a lymphopenia, following which homeostatic reconstitution leads to prolonged alteration of the immune repertoire. This reduces the risk of relapse and disability accumulation in multiple sclerosis; it is the only drug to show superiority over interferon β-1a in disability outcomes in a monotherapy phase III trial. It should be used with a parallel risk management programme to identify the principal adverse effects of alemtuzumab, especially secondary autoimmunity months or years later, mainly against the thyroid but also immune thrombocytopenia. This review charts the development of alemtuzumab as a drug for multiple sclerosis and summarizes the latest clinical trial data.
authors: Department of Clinical Neurosciences, University of Cambridge, Level 6, Block A, Box 165, Addenbrookes Hospital, Hills Road, Cambridge CB2 0QQ, UK.
authors: Onajite
authors: O
authors: Kousin-Ezewu
authors: Alasdair
authors: A
authors: Coles
keywords: alemtuzumab; autoimmunity; monoclonal antibodies; multiple sclerosis
references: Brain. 1996 Feb;119 ( Pt 1):225-37
references: 8624684
references: Brain. 2000 Jun;123 ( Pt 6):1102-11
references: 10825350
references: Blood. 2002 May 15;99(10):3554-61
references: 11986207
references: Ann Neurol. 1999 Sep;46(3):296-304
references: 10482259
references: Blood. 1989 May 1;73(6):1431-9
references: 2713487
references: Lancet. 2012 Nov 24;380(9856):1829-39
references: 23122650
references: Endocrine. 2011 Feb;39(1):13-20
references: 21061094
references: J Neurol. 2006 Jan;253(1):98-108
references: 16044212
references: Philos Trans R Soc Lond B Biol Sci. 2005 Sep 29;360(1461):1707-11
references: 16147535
references: Rheumatology (Oxford). 2003 Dec;42(12):1539-44
references: 12949252
references: J Clin Invest. 2009 Jul;119(7):2052-61
references: 19546505
references: J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):298-304
references: 22056965
references: Lancet. 1999 Nov 13;354(9191):1691-5
references: 10568572
references: Blood. 1983 Oct;62(4):873-82
references: 6349718
references: Ann Neurol. 2004 Oct;56(4):548-55
references: 15389896
references: Nature. 1975 Aug 7;256(5517):495-7
references: 1172191
references: PLoS One. 2012;7(6):e39416
references: 22761788
references: Lancet. 2012 Nov 24;380(9856):1819-28
references: 23122652
references: Nature. 1988 Mar 24;332(6162):323-7
references: 3127726
references: J Neurol. 2008 Feb;255(2):231-8
references: 18283404
references: Eur J Neurol. 2012 Feb;19(2):307-11
references: 21899662
references: Lancet Neurol. 2011 Apr;10(4):338-48
references: 21397567
references: Lancet. 1984 Sep 1;2(8401):483-6
references: 6147548
references: Eur J Immunol. 1991 Jul;21(7):1677-84
references: 1711975
references: Blood. 1993 Aug 1;82(3):807-12
references: 7687895
references: Lancet. 1998 Dec 12;352(9144):1907-8
references: 9863795
references: Neurology. 2012 Apr 3;78(14):1069-78
references: 22442431
references: Sci Transl Med. 2012 Jan 18;4(117):117ra7
references: 22261031
references: Lancet. 1994 Jul 30;344(8918):298-301
references: 7914262
references: Bone Marrow Transplant. 2001 Dec;28(12):1151-3
references: 11803358
references: Cell. 2004 Apr 16;117(2):265-77
references: 15084263
references: Lancet Neurol. 2009 Jun;8(6):545-59
references: 19446274
references: Nature. 1984 Dec 6-12;312(5994):548-51
references: 6150440
references: Br J Surg. 2000 Aug;87(8):1111-3
references: 10931060
references: Immunotherapy. 2010 Nov;2(6):783-90
references: 21091110
references: Arch Immunol Ther Exp (Warsz). 2012 Apr;60(2):99-106
references: 22307362
references: Eur J Neurol. 2009 Nov;16(11):1202-9
references: 19538207
references: Clin Endocrinol (Oxf). 2004 Jun;60(6):719-25
references: 15163336
references: N Engl J Med. 2008 Aug 14;359(7):768-9
references: 18703487
references: Expert Rev Neurother. 2012 Mar;12(3):335-41
references: 22364332